Ritesh K Srivastava Selected Research

lewisite

11/2020	Protective role of HO-1 against acute kidney injury caused by cutaneous exposure to arsenicals.
1/2018	Cutaneous exposure to lewisite causes acute kidney injury by invoking DNA damage and autophagic response.
10/2016	Molecular Mechanism Underlying Pathogenesis of Lewisite-Induced Cutaneous Blistering and Inflammation: Chemical Chaperones as Potential Novel Antidotes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ritesh K Srivastava Research Topics

Disease

7	Neoplasms (Cancer) 12/2019 - 01/2013
4	Inflammation (Inflammations) 01/2022 - 10/2016
4	Residual Neoplasm 01/2022 - 06/2013
3	Rhabdomyosarcoma 01/2022 - 06/2013
2	Acute Kidney Injury (Acute Renal Failure) 11/2020 - 01/2018
2	Skin Neoplasms (Skin Cancer) 02/2014 - 01/2013
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2014 - 01/2013
1	Pain (Aches) 01/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Edema (Dropsy) 01/2022
1	Communicable Diseases (Infectious Diseases) 10/2016
1	Neuroblastoma 02/2015
1	Alveolar Rhabdomyosarcoma 12/2014
1	Genomic Instability 11/2014
1	Carcinogenesis 02/2014
1	Body Weight (Weight, Body) 01/2013
1	Lung Neoplasms (Lung Cancer) 06/2011

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2014
4	ArsenicIBA 10/2016 - 09/2013
3	Arsenicals (Arsenic Compounds)IBA 01/2022 - 10/2016
3	lewisiteIBA 11/2020 - 10/2016
2	Cyclin D1IBA 01/2022 - 02/2014
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2022 - 12/2019
2	Irritants (Vesicants)IBA 01/2022 - 11/2020
2	Biomarkers (Surrogate Marker)IBA 11/2020 - 06/2013
1	Pharmaceutical PreparationsIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	Heme Oxygenase-1IBA 11/2020
1	TOR Serine-Threonine KinasesIBA 12/2019
1	OSI 027IBA 12/2019
1	Mechanistic Target of Rapamycin Complex 2IBA 12/2019
1	PP242IBA 12/2019
1	oxophenylarsine (phenylarsine oxide)IBA 01/2018
1	4-phenylbutylamineIBA 10/2016
1	Chemical Warfare AgentsIBA 10/2016
1	AldehydesIBA 02/2015
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 02/2015
1	GANT 61IBA 12/2014
1	Mitogen-Activated Protein KinasesIBA 11/2014
1	MetalloidsIBA 11/2014
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 02/2014
1	CateninsIBA 02/2014
1	XAV939IBA 02/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2014
1	ERB 041IBA 02/2014
1	Sirolimus (Rapamycin)FDA Link 06/2013
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2013
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2013
1	Antineoplastic Agents (Antineoplastics)IBA 01/2013
1	Histone Deacetylase InhibitorsIBA 01/2013
1	Vorinostat FDA Link 01/2013
1	Carbon Nanotubes (Carbon Nanotube)IBA 06/2011